N2 is pleased to announce the release of the ICH E6 R2-GCP updated Good Clinical Practice (GCP) Basic Course. The 10-module course is now available through the Collaborative Institutional Training Initiative (CITI).
Previously 13-modules, this 10-module course discusses good clinical practice as it relates to clinical trials. The discussion is focused on the International Council for Harmonisation (ICH)-E6 (R2) guidelines and applicable regulations in Canada such as Health Canada-Division 5, and The Tri-Council Policy Statement 2.
This is significant in that N2 has worked with TransCelerate to assure that the high-quality CITI Canada GCP course accessible to N2 members meets their standards. This means if you are working with a TransCelerate affiliated company you can assure them that your CITI Canada training has formal approval and recognition from TransCelerate. Meeting TransCelerate training criteria is the latest milestone in a trend that has seen many biopharmaceutical companies as well as research networks, hospitals and universities accept the CITI Canada GCP course as their gold standard.
For more information please review the article “How to Determine if a GCP Course Meets TransCelerate BioPharma Minimum Criteria” which provides a brief overview of the TransCelerate certification.
For more CITI updates please click here.
